eXoZymes selects Curia as commercial-scale manufacturing partner for NCT
eXoZymes (NASDAQ:EXOZ) said it entered into an agreement with Curia Global as its commercial-scale manufacturing partner for NCT.
LOS ANGELES, CA / / September 8, 2026 / Today, eXoZymes Inc. NASDAQ:EXOZ ("eXoZymes") said it has entered into an agreement with Curia Global, Inc. ("Curia") for commercial-scale manufacturing of NCT. The company said the partnership is intended to support future production as it advances development of NCT.